Abstract
PD-L1 and VISTA are thought to play a role in escape from the immune system, tumor progression and treatment response in tumoral tissue. It has been suggested that radiotherapy may increase the expression levels of immune biomarkers. The current study aimed to evaluate the effects of radiotherapy (RT) and chemoradiotherapy (CRT) on PD-L1 and VISTA expression in head and neck cancers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have